Description:

1. Active Substance:
   • Strattera contains the active ingredient atomoxetine, which is a selective norepinephrine reuptake inhibitor (SNRI). Atomoxetine is used in the treatment of attention deficit hyperactivity disorder (ADHD) in children, adolescents, and adults.
2. Medical Uses:
   • ADHD Treatment: Strattera is indicated for the treatment of ADHD as part of a comprehensive treatment plan that may include psychological, educational, and social interventions. It helps improve attention span, focus, and impulse control in individuals with ADHD.
3. Mode of Action:
   • Atomoxetine works by inhibiting the reuptake of norepinephrine, a neurotransmitter involved in the regulation of attention, impulse control, and executive function. By increasing the availability of norepinephrine in the brain, atomoxetine helps modulate neurotransmission and improve ADHD symptoms.
4. Dosage and Administration:
   • The dosage of Strattera is determined by a healthcare professional based on factors such as the patient’s age, weight, and individual response to treatment.
   • It is typically taken orally in the form of capsules, usually once or twice daily. The capsules can be taken with or without food, but consistent administration with regards to food intake is recommended.
5. Side Effects:
   • Common side effects of Strattera may include:
     • Gastrointestinal symptoms such as nausea, vomiting, and stomach upset
     • Decreased appetite and weight loss
     • Insomnia or sleep disturbances
     • Dry mouth
     • Headache and dizziness
     • Mood changes or irritability
   • Rare but more serious side effects may include liver injury, cardiovascular effects (such as increased heart rate and blood pressure), and suicidal ideation, particularly in children and adolescents.
6. Precautions:
   • Before using Strattera, individuals should inform their healthcare provider about any existing medical conditions, especially heart problems, high blood pressure, liver or kidney disease, and psychiatric disorders.
   • Strattera may interact with certain medications, including monoamine oxidase inhibitors (MAOIs), and should not be used concomitantly with these drugs.
   • Regular monitoring of blood pressure, heart rate, and liver function is recommended during treatment with Strattera, especially in patients with pre-existing cardiovascular or hepatic conditions.
7. Prescription Required:
   • Yes, Strattera is a prescription medication, and its use should be guided by a healthcare professional’s prescription.
8. Note:
   • Strattera is a non-stimulant medication for ADHD, unlike traditional stimulant medications such as methylphenidate or amphetamine-based drugs. It may be preferred in individuals who do not tolerate stimulants well or have a history of substance abuse.
   • It may take several weeks of treatment with Strattera to experience the full therapeutic effects, and dosage adjustments may be necessary based on individual response and tolerability.

It’s essential for individuals prescribed Strattera to follow their healthcare provider’s instructions carefully, report any side effects or concerns promptly, and attend regular follow-up appointments to monitor treatment response and safety.